Heptares Therapeutics
Gabriella Cseke has extensive work experience in the field of scientific research. Gabriella started their career at NIMR as a Postdoctoral Fellow in November 2006 and continued working there until September 2009. Gabriella then joined GSK in 2009 as a Scientist. After working for GSK for a year, they moved on to Heptares in 2010, where they held the position of Research Scientist. Gabriella remained with Heptares until 2019 when they joined Sosei Heptares as a Senior Scientist.
Gabriella Cseke attended Vanderbilt University from 2002 to 2006. During their time there, they pursued a Doctor of Philosophy (PhD) degree in Chemistry.
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.